212 related articles for article (PubMed ID: 21606539)
1. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.
Kuniholm MH; Gao X; Xue X; Kovacs A; Marti D; Thio CL; Peters MG; Greenblatt RM; Goedert JJ; Cohen MH; Minkoff H; Gange SJ; Anastos K; Fazzari M; Young MA; Strickler HD; Carrington M
J Infect Dis; 2011 Jun; 203(12):1807-14. PubMed ID: 21606539
[TBL] [Abstract][Full Text] [Related]
2. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
[TBL] [Abstract][Full Text] [Related]
3. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
Bambha K; Pierce C; Cox C; French AL; Tien PC; Sharp GB; Augenbraun M; Glesby MJ; Villacres MC; Plankey M; Strickler HD; Gange SJ; Peters MG
AIDS; 2012 Mar; 26(5):599-607. PubMed ID: 22156972
[TBL] [Abstract][Full Text] [Related]
4. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort.
Chalouni M; Sogni P; Miailhes P; Lacombe K; Poizot-Martin I; Chas J; Vittecoq D; Neau D; Aumaitre H; Alric L; Piroth L; Bouchaud O; Katlama C; Morlat P; Lascoux-Combe C; Gervais A; Naqvi A; Rosenthal E; Garipuy D; Barange K; Esterle L; Salmon D; Wittkop L;
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1387-1396. PubMed ID: 31033848
[TBL] [Abstract][Full Text] [Related]
5. Real life application of FIB-4 & APRI during mass treatment of HCV genotype 4 with directly acting anti-viral agents in Egyptian patients, an observational study.
Said M; Soliman Z; Daebes H; M El-Nahaas S; El-Serafy M
Expert Rev Gastroenterol Hepatol; 2019 Dec; 13(12):1189-1195. PubMed ID: 31702417
[No Abstract] [Full Text] [Related]
6. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
7. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
9. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
Peters MG; Bacchetti P; Boylan R; French AL; Tien PC; Plankey MW; Glesby MJ; Augenbraun M; Golub ET; Karim R; Parkes J; Rosenberg W
AIDS; 2016 Mar; 30(5):723-9. PubMed ID: 26595542
[TBL] [Abstract][Full Text] [Related]
10. Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals.
Bavaro DF; Saracino A; Fiordelisi D; Bruno G; Ladisa N; Monno L; Angarano G
J Med Virol; 2019 May; 91(5):751-757. PubMed ID: 30578670
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
[TBL] [Abstract][Full Text] [Related]
13. Acoustic Radiation Force Impulse Elastography with APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients.
Tseng CH; Chang CY; Mo LR; Lin JT; Tai CM; Perng DS; Lin CW; Hsu YC
Ann Hepatol; 2018 Aug; 17(5):789-794. PubMed ID: 30145564
[TBL] [Abstract][Full Text] [Related]
14. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis.
Jain MK; Seremba E; Bhore R; Dao D; Joshi R; Attar N; Yuan HJ; Lee WM
AIDS Patient Care STDS; 2012 Feb; 26(2):73-80. PubMed ID: 22239101
[TBL] [Abstract][Full Text] [Related]
15. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.
Renou C; Halfon P; Pol S; Cacoub P; Jouve E; Bronowicki JP; Arpurt JP; Rifflet H; Picon M; Causse X; Canva V; Denis J; Tran A; Bourliére M; Ouzan D; Pariente A; Dantin S; Alric L; Cartier V; Reville M; Caillat-Zucman S
Gut; 2002 Oct; 51(4):585-90. PubMed ID: 12235085
[TBL] [Abstract][Full Text] [Related]
16. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
17. Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan.
Tseng KC; Tseng CW; Hsieh YH; Chang CK; Lai NS; Hung TH; Chang TT
Hum Immunol; 2013 Aug; 74(8):978-82. PubMed ID: 23628398
[TBL] [Abstract][Full Text] [Related]
18. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.
Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L
Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
[TBL] [Abstract][Full Text] [Related]
20. High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.
Berenguer J; Fernandez-Rodríguez A; Jimenez-Sousa MA; Cosín J; Zarate P; Micheloud D; López JC; Miralles P; Catalán P; Resino S
Cytokine; 2012 Jan; 57(1):25-9. PubMed ID: 22136974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
